(Sharecast News) - Futura Medical announced encouraging progress in its product development pipeline on Monday, with successful proof-of-concept results for two new treatments addressing sexual dysfunction.
The AIM-traded company said it was expanding its product range beyond its flagship product, Eroxon, with the introduction of WSD4000, a potential over-the-counter treatment for...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE